Mark Schroeder Biography and Net Worth



Mark S. Schroeder serves as Executive Vice President, President of Diagnostics Laboratory Operations and Global Supply Chain of the Company. From March 2016 until then, Mr. Schroeder served as Chief Supply Chain Officer. In that role, he was responsible for LabCorp’s global supply chain management function and overseeing Diagnostics and Drug Development supply chain operations around the world. Prior to that role, he served as Senior Vice President, Integrated Genetics, Oncology and Supply Chain Operations from 2014 to 2016. He was the Senior Vice President, Supply Chain Operations prior to that role, a position he held since joining the Company in May 2007. Mr. Schroeder serves on the FedEx Healthcare Industry Advisory Board. Mr. Schroeder holds a Bachelor’s degree in Interdisciplinary Engineering and Management from Clarkson University.

What is Mark S. Schroeder's net worth?

The estimated net worth of Mark S. Schroeder is at least $1.47 million as of May 18th, 2023. Mr. Schroeder owns 6,687 shares of Laboratory Co. of America stock worth more than $1,465,523 as of February 26th. This net worth approximation does not reflect any other investments that Mr. Schroeder may own. Additionally, Mr. Schroeder receives a salary of $1,060,000.00 as EVP at Laboratory Co. of America. Learn More about Mark S. Schroeder's net worth.

How old is Mark S. Schroeder?

Mr. Schroeder is currently 63 years old. There are 7 older executives and no younger executives at Laboratory Co. of America. The oldest executive at Laboratory Co. of America is Dr. Marcia T. Eisenberg Ph.D., Chief Scientific Officer & Senior VP, who is 65 years old. Learn More on Mark S. Schroeder's age.

What is Mark S. Schroeder's salary?

As the EVP of Laboratory Co. of America Holdings, Mr. Schroeder earns $1,060,000.00 per year. There are 3 executives that earn more than Mr. Schroeder. The highest earning executive at Laboratory Co. of America is Mr. Adam H. Schechter, President, CEO & Chairman, who commands a salary of $3,720,000.00 per year. Learn More on Mark S. Schroeder's salary.

How do I contact Mark S. Schroeder?

The corporate mailing address for Mr. Schroeder and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Mark S. Schroeder's contact information.

Has Mark S. Schroeder been buying or selling shares of Laboratory Co. of America?

Mark S. Schroeder has not been actively trading shares of Laboratory Co. of America during the last ninety days. Most recently, Mark S. Schroeder sold 1,500 shares of the business's stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $216.77, for a transaction totalling $325,155.00. Following the completion of the sale, the chief operating officer now directly owns 6,687 shares of the company's stock, valued at $1,449,540.99. Learn More on Mark S. Schroeder's trading history.

Who are Laboratory Co. of America's active insiders?

Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.

Are insiders buying or selling shares of Laboratory Co. of America?

During the last year, insiders at the medical research company sold shares 10 times. They sold a total of 51,793 shares worth more than $11,208,958.28. The most recent insider tranaction occured on February, 21st when CFO Glenn A Eisenberg sold 34,504 shares worth more than $7,451,828.88. Insiders at Laboratory Co. of America own 0.7% of the company. Learn More about insider trades at Laboratory Co. of America.

Information on this page was last updated on 2/21/2024.

Mark S. Schroeder Insider Trading History at Laboratory Co. of America

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2023Sell1,500$216.77$325,155.006,687View SEC Filing Icon  
3/31/2023Sell3,897$225.81$879,981.576,687View SEC Filing Icon  
2/14/2023Sell309$247.63$76,517.676,687View SEC Filing Icon  
11/8/2022Sell1,116$232.67$259,659.726,687View SEC Filing Icon  
3/29/2022Sell2,356$277.11$652,871.16View SEC Filing Icon  
2/15/2022Sell207$273.98$56,713.86View SEC Filing Icon  
2/7/2022Sell204$277.38$56,585.52View SEC Filing Icon  
2/3/2022Sell161$271.81$43,761.41View SEC Filing Icon  
3/30/2021Sell667$251.88$168,003.965,006View SEC Filing Icon  
11/6/2020Sell588$214.59$126,178.923,949View SEC Filing Icon  
2/13/2020Sell188$188.49$35,436.12533View SEC Filing Icon  
2/10/2020Sell108$181.99$19,654.92View SEC Filing Icon  
See Full Table

Mark S. Schroeder Buying and Selling Activity at Laboratory Co. of America

This chart shows Mark S Schroeder's buying and selling at Laboratory Co. of America by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Laboratory Co. of America Company Overview

Laboratory Co. of America logo
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
Read More

Today's Range

Now: $219.62
Low: $218.01
High: $219.94

50 Day Range

MA: $223.81
Low: $215.65
High: $232.56

2 Week Range

Now: $219.62
Low: $174.20
High: $234.09

Volume

53,767 shs

Average Volume

693,297 shs

Market Capitalization

$18.65 billion

P/E Ratio

47.03

Dividend Yield

1.31%

Beta

1.04
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
You've got to see it